Back to Journals » International Journal of Nanomedicine » Volume 9 » Issue 1

Effect of nanostructured TiO2 crystal phase on photoinduced apoptosis of breast cancer epithelial cells

Authors Lagopati N, Tsilibary EP, Falaras P, Papazafiri P, Pavlatou EA, Kotsopoulou E, Kitsiou P

Received 24 February 2014

Accepted for publication 1 April 2014

Published 3 July 2014 Volume 2014:9(1) Pages 3219—3230

DOI https://doi.org/10.2147/IJN.S62972

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Nefeli Lagopati,1,2 Effie-Photini Tsilibary,1,* Polycarpos Falaras,2,* Panagiota Papazafiri,3 Evangelia A Pavlatou,4 Eleni Kotsopoulou,1 Paraskevi Kitsiou1,*

1Institute of Biosciences and Applications, 2Institute of Advanced Materials, Physicochemical Processes, Nanotechnology and Microsystems, National Center for Scientific Research “Demokritos”, Athens, Greece; 3Department of Animal and Human Physiology, Faculty of Biology, School of Science, National and Kapodistrian University of Athens, Athens, Greece; 4Laboratory of General Chemistry, School of Chemical Engineering, National Technical University of Athens, Athens, Greece

*These authors contributed equally to this work

Purpose: The use of nanoparticles has seen exponential growth in the area of health care, due to the unique physicochemical properties of nanomaterials that make them desirable for medical applications. The aim of this study was to examine the effects of crystal phase-nanostructured titanium dioxide particles on bioactivity/cytotoxicity in breast cancer epithelial cells.
Materials and methods: Cultured Michigan Cancer Foundation (MCF)-7 and human breast adenocarcinoma (MDA-MB-468) breast cancer epithelial cells were exposed to ultraviolet A light (wavelength 350 nm) for 20 minutes in the presence of aqueous dispersions of two different nanostructured titanium dioxide (TiO2) crystal phases: anatase and an anatase–rutile mixture. Detailed characterization of each titanium dispersion was performed by dynamic light scattering. A 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) colorimetric assay was employed to estimate the percentage of viable cells after each treatment. Western blot analysis of protein expression and characterization, as well as a deoxyribonucleic acid (DNA)-laddering assay, were used to detect cell apoptosis.
Results: Our results documented that 100% anatase TiO2 nanoparticles (110–130 nm) exhibited significantly higher cytotoxicity in the highly malignant MDA-MB-468 cancer cells than anatase–rutile mixtures (75%/25%) with the same size. On the contrary, MCF-7 cells (characterized by low invasive properties) were not considerably affected. Exposure of MDA-MB-468 cells to pure anatase nanoparticles or anatase–rutile mixtures for 48 hours resulted in increased proapoptotic Bax expression, caspase-mediated poly(adenosine diphosphate ribose) polymerase (PARP) cleavage, DNA fragmentation, and programmed cell death/apoptosis.
Conclusion: The obtained results indicated that pure anatase TiO2 nanoparticles exhibit superior cytotoxic effects compared to anatase–rutile mixtures of the same size. The molecular mechanism of TiO2 nanoparticle cytotoxicity involved increased Bax expression and caspase-mediated PARP inactivation, thus resulting in DNA fragmentation and cell apoptosis.

Keywords: nanostructured TiO2, anatase, rutile, photocatalysis, breast cancer epithelial cells, apoptosis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages

Dubey A, Park DW, Kwon JE, Jeong YJ, Kim T, Kim I, Kang SC, Chi KW

International Journal of Nanomedicine 2015, 10:227-240

Published Date: 2 September 2015

Biocompatible and biodegradable fibrinogen microspheres for tumor-targeted doxorubicin delivery

Joo JY, Park GY, An SSA

International Journal of Nanomedicine 2015, 10:101-111

Published Date: 1 September 2015

Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies

Capolla S, Garrovo C, Zorzet S, Lorenzon A, Rampazzo E, Spretz R, Pozzato G, Núñez L, Tripodo C, Macor P, Biffi S

International Journal of Nanomedicine 2015, 10:4099-4109

Published Date: 22 June 2015

Cytotoxic effects of curcumin in osteosarcoma cells

Moran JM, Rodriguez-Velasco FJ, Roncero-Martin R, Vera V, Pedrera-Zamorano JD

International Journal of Nanomedicine 2014, 9:5273-5275

Published Date: 14 November 2014

Toxicology of antimicrobial nanoparticlesfor prosthetic devices

Nuñez-Anita RE, Acosta-Torres LS, Vilar-Pineda J, Martínez-Espinosa JC, de la Fuente-Hernández J, Castaño VM

International Journal of Nanomedicine 2014, 9:3999-4006

Published Date: 20 August 2014

Pluronic® L64-mediated stable HIF-1α expression in muscle for therapeutic angiogenesis in mouse hindlimb ischemia

Song H, Liu S, Li C, Geng Y, Wang G, Gu Z

International Journal of Nanomedicine 2014, 9:3439-3452

Published Date: 21 July 2014

Electrospun vancomycin-loaded coating on titanium implants for the prevention of implant-associated infections

Zhang L, Yan JW, Yin ZW, Tang C, Guo Y, Li D, Wei B, Xu Y, Gu QR, Wang LM

International Journal of Nanomedicine 2014, 9:3027-3036

Published Date: 23 June 2014

Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures

Blakney AK, Krogstad EA, Jiang YH, Woodrow KA

International Journal of Nanomedicine 2014, 9:2967-2978

Published Date: 17 June 2014